Copyright
©The Author(s) 2020.
World J Clin Cases. Apr 26, 2020; 8(8): 1424-1443
Published online Apr 26, 2020. doi: 10.12998/wjcc.v8.i8.1424
Published online Apr 26, 2020. doi: 10.12998/wjcc.v8.i8.1424
Table 12 Administered antibodies in the second-line setting according to RAS mutation status and time to progression-free survival
| RAS status | Bevacizumab, n (%) | PFS | Panitumumab, n (%) | PFS | Aflibercept, n (%) | PFS | Total, n (%) | PFS | |
| LCC | RAS wild type | 16 (16.5) | 7.4 | 20 (20.6) | 8.1 | 10 (10.3) | 6.8 | 46 (47.4) | 7.9 |
| RAS mutant | 9 (9.3) | 9 | - | - | 19 (19.6) | 9.3 | 28 (28.9) | 9.0 | |
| Total | 25 (25.8) | 7.4 | 20 (20.6) | 8.1 | 29 (29.9) | 8.2 | 74 (76.3) | 8.2 | |
| RCC | RAS wild type | 2 (2.1) | 4.4 | 6 (6.2) | 12.3 | 1 (1.0) | 7.7 | 9 (9.3) | 9.0 |
| RAS mutant | 7 (7.3) | 10.4 | - | - | 7 (7.3) | 7.0 | 14 (14.4) | 12.3 | |
| Total | 9 (9.3) | 10.4 | 6 (6.2) | 12.3 | 8 (8.3) | 7.1 | 23 (23.4) | 8.6 | |
| 34 (34.5) | 9.0 | 26 (26.8) | 9.7 | 37 (38.1) | 7.6 | 97 (100) | 8.6 |
- Citation: Kalantzis I, Nonni A, Pavlakis K, Delicha EM, Miltiadou K, Kosmas C, Ziras N, Gkoumas K, Gakiopoulou H. Clinicopathological differences and correlations between right and left colon cancer. World J Clin Cases 2020; 8(8): 1424-1443
- URL: https://www.wjgnet.com/2307-8960/full/v8/i8/1424.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i8.1424